Shareholders meeting

MANUFACTURER OF BULK DRUGS & IMPORTERS OF SOLVENTS & CHEMICALS H.O: 203/4 SAHAKAR BHAVAN, 340/48 N.N STREET, MUMBAI-400009 : (022) 23455543 Email: corporate@aareydrugs.com REGD OFF. & FACTORY: E-34 MIDC, TARAPUR, BOISAR, DIST.-THANE (02525) 271049 Email: info@aareydrugs.com CIN:L99999MH1990PLC056538 Date: 30th September 2026 BSE Limited National Stock Exchange of India Limited The Manager, Exchange Plaza Corporate Service Department Bandra Kurla Complex, P.J. Towers, Dalal Street, Bandra (E), Mumbai- 400 001 Mumbai – 400051 Scrip Code: 524412 NSE Symbol: AAREYDRUGS Subject: Summary of Proceedings of the 36th Annual General Meeting held on Wednesday, 30th September, 2026. Ref: - Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015. Dear Sir/Ma’am, This is to inform that 36th Annual General Meeting (AGM) of the Company was held on Wednesday, the 30th September, 2026 commenced at 03:00 P.M. and concluded at 3:20 P.M. by OAVM means. Chairman of the meeting Mr. Mihir Ghatalia presided over the proceedings and welcomed the Members to the 36th AGM of the Company. The Company Secretary through his representative informed that the required quorum was present and called the meeting in order. The Chairman then addressed the members and gave an overview of the financial performance of the Company for the Financial Year 2025-2026 and the general working operations of the Company and its future outlook. The Company Secretary through his representative informed that the Company provided remote e-voting facility to the members to vote on the matters transacted at the 36thAGM, Further, to facilitate the voting at Annual General Meeting to the members present there at and who did not cast their vote earlier through remote e-voting, the Company provided to vote during the meeting in respect of items of business as set out in the Notice of Annual General Meeting. Mr. Virendra G. Bhatt, Practicing Company Secretary was appointed as the Scrutinizer for the E-voting process. With the permission of the Chairman, he explained to the shareholders the resolutions put forth for approval. I. To consider and adopt the Audited Financial Statements of the Company for the financial year ended 31stMarch, 2026 together with the Reports of the Directors and Auditors thereon. II. To appoint a director in place of Mrs. Bina Ghatalia (DIN: 01471745), who retires by rotation and being eligible, offer herself for re-appointment. III. Approval of Related Party Transactions. Then members were invited to raise questions, offer comments and seek clarifications on the Annual Report and Accounts or any of the items stated in the Notice of the 36thAnnual General Meeting of the Company. MANUFACTURER OF BULK DRUGS & IMPORTERS OF SOLVENTS & CHEMICALS H.O: 203/4 SAHAKAR BHAVAN, 340/48 N.N STREET, MUMBAI-400009 : (022) 23455543 Email: corporate@aareydrugs.com REGD OFF. & FACTORY: E-34 MIDC, TARAPUR, BOISAR, DIST.-THANE (02525) 271049 Email: info@aareydrugs.com CIN:L99999MH1990PLC056538 further members were informed that in accordance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company shall submit to the Stock Exchange the details of the voting results in the prescribed format within 2 working days of conclusion of the AGM. The Members were requested to cast votes on the Resolutions to those who have not cast their votes through remote E-voting, and informed that the venue E-voting facility in the Meeting will remain active till 30 minutes after closing of the Meeting. With the consent of all Board Members and the Shareholders, meeting was closed with thanks to Chairman, Board Members, and other Key Stakeholders. The Chairman thanked all the members for their presence and support and after the casting of the votes by all the members present, the 36thAGM stood closed. Please take a note of the same and oblige. Thanking you, Yours faithfully, For AAREY DRUGS & PHARMACEUTICALS LIMITED Nimit Ghatalia Director DIN: 07069841